A new class of hole-transporting
spirothioxanthene derivatives
has been synthesized and characterized. Their photophysical, electrochemical
and thermal properties have been studied. These compounds exhibit
high hole mobilities of up to 1 × 10–3 cm2 V–1 s–1, determined by
using thin film transistor technique. In addition, these spirothioxanthene
derivatives are promising donor materials in the construction of high
performance organic photovoltaic (OPV) devices. With a very low dopant
concentration of 7%, highly efficient small molecule-based OPV devices
with high short-circuit current density of 10.83 mA cm–2, open-circuit voltage of 0.94 V, and high power conversion efficiency
of 5.40% (the highest PCE of 5.46%) have been realized.
A series of heterocyclic spiro derivatives has been successfully synthesized and characterized by photophysical and electrochemical studies. Taking advantage of their excellent hole-transporting properties, highly efficient small-molecular organic photovoltaic devices based on these heterocyclic compounds as donors with very low dopant concentrations have been prepared; particularly, a high open-circuit voltage of up to 1.10 V and a power conversion efficiency of up to 5.12% have been realized. In addition, most of these heterocyclic spiro derivatives are found to be highly emissive in solutions with photoluminescence quantum yields of up to 0.91, and high-performance deep-blue-emitting organic light-emitting diodes (OLEDs) have been achieved. Such devices exhibit a stable deep blue emission with CIE coordinates of (0.16, 0.04) and high external quantum efficiencies of up to 4.7%, which is one of the best values among the reported OLEDs with CIEy < 0.08.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.